Literature DB >> 25044419

Enhancing the stiffness of collagen hydrogels for delivery of encapsulated chondrocytes to articular lesions for cartilage regeneration.

Mark A Omobono1, Xing Zhao, Michael A Furlong, Chi-Heon Kwon, Thomas J Gill, Mark A Randolph, Robert W Redmond.   

Abstract

This study investigated a dual crosslinking paradigm, consisting of (a) photocrosslinking with Rose Bengal (RB) and green light followed by (b) chemical crosslinking with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), and N-hydroxysuccinimide (NHS) to enhance collagen gel stiffness. In group 1, 50 μL collagen constructs of 2% (w/v) type I collagen containing 10 μM RB were allowed to gel spontaneously at 37 °C. In group 2, the spontaneous gels were exposed to green light (532 nm). In group 3, the photochemically crosslinked gels were subsequently treated with a 1-h exposure to 33 mM EDC/6 mM NHS. Samples (n = 18) were subjected to 0.08% (w/v) collagenase digestion, and the storage modulus of samples was measured by rheometry. Viability of encapsulated chondrocytes was measured by live/dead assay. Chondrocytes were ≥ 95% viable in all constructs at 10 days in vitro. Resistance to collagenase digestion increased as; spontaneous gels (2 h) < photochemical gels (3-4 h) < dual crosslinked gels (>24 h). The storage modulus of dual-crosslinked constructs was increased 5-fold over both photocrosslinked and spontaneous gels. As the dual crosslinking paradigm did not reduce encapsulated chondrocyte viability, these crosslinked collagen hydrogels could be a useful tool for the practical delivery of encapsulated chondrocytes to articular defects.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  cartilage tissue engineering; collagen; crosslinking; hydrogel; scaffold

Mesh:

Substances:

Year:  2014        PMID: 25044419     DOI: 10.1002/jbm.a.35266

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  7 in total

1.  Dual crosslinking strategy to generate mechanically viable cell-laden printable constructs using methacrylated collagen bioinks.

Authors:  Nilabh S Kajave; Trevor Schmitt; Thuy-Uyen Nguyen; Vipuil Kishore
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2019-10-09       Impact factor: 7.328

Review 2.  Photopolymerizable Biomaterials and Light-Based 3D Printing Strategies for Biomedical Applications.

Authors:  Claire Yu; Jacob Schimelman; Pengrui Wang; Kathleen L Miller; Xuanyi Ma; Shangting You; Jiaao Guan; Bingjie Sun; Wei Zhu; Shaochen Chen
Journal:  Chem Rev       Date:  2020-04-23       Impact factor: 60.622

Review 3.  Cross-linking methods of type I collagen-based scaffolds for cartilage tissue engineering.

Authors:  Yu-Han Jiang; Ying-Yue Lou; Teng-Hai Li; Bing-Zhang Liu; Kang Chen; Duo Zhang; Tian Li
Journal:  Am J Transl Res       Date:  2022-02-15       Impact factor: 4.060

Review 4.  Advances in Regenerative Medicine and Tissue Engineering: Innovation and Transformation of Medicine.

Authors:  Kevin Dzobo; Nicholas Ekow Thomford; Dimakatso Alice Senthebane; Hendrina Shipanga; Arielle Rowe; Collet Dandara; Michael Pillay; Keolebogile Shirley Caroline M Motaung
Journal:  Stem Cells Int       Date:  2018-07-30       Impact factor: 5.443

Review 5.  Functional Hydrogels With Tunable Structures and Properties for Tissue Engineering Applications.

Authors:  Xiaomeng Li; Qingqing Sun; Qian Li; Naoki Kawazoe; Guoping Chen
Journal:  Front Chem       Date:  2018-10-22       Impact factor: 5.221

6.  MagneTEskin-Reconstructing skin by magnetically induced assembly of autologous microtissue cores.

Authors:  Christiane Fuchs; Linh Pham; Ying Wang; William A Farinelli; R Rox Anderson; Joshua Tam
Journal:  Sci Adv       Date:  2021-10-08       Impact factor: 14.136

7.  Articular cartilage generation applying PEG-LA-DM/PEGDM copolymer hydrogels.

Authors:  Xing Zhao; Anestis Papadopoulos; Shinichi Ibusuki; David A Bichara; Daniel B Saris; Jos Malda; Kristi S Anseth; Thomas J Gill; Mark A Randolph
Journal:  BMC Musculoskelet Disord       Date:  2016-06-03       Impact factor: 2.362

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.